Chemical and Biological Medical Treatment Symposium V (CBMTS V)

Venue: Spiez Laboratory

Location: Spiez, Switzerland

Event Date/Time: Apr 25, 2004 End Date/Time: Apr 30, 2004
Registration Date: Apr 18, 2004
Early Registration Date: Feb 25, 2004
Abstract Submission Date: Feb 29, 2004
Paper Submission Date: Apr 01, 2004
Report as Spam


Bring together the CBMTS professionals most concerned with and directly involved in the scientific and technical aspects of problems associated with the CBR threat to include all actions associated with CBR agent, agrichemical, agrochemical and industrial poisonings. These problems include medical treatment (prophylaxis, pre-treatment and therapy) required for CB agent, agrichemical and industrial poisonings; emergency management required for accidents and incidents; and operational issues from across the response spectrum. Contributions of papers and posters from each research and operational area are solicited.
Who Should Attend?

Industry, government and academic professionals with an interest in the chemical, biological, and radiological threat, whether the threat is from war, terrorist actions or accidents and incidents, natural or man-made. Medical, public health and medical research professionals, including primary care physicians, practitioners and veterinarians; Local, regional and national laboratory representatives; firstresponders and HAZMAT specialists, including emergency, crisis management and mitigation, and civil defense personnel; industry scientists and engineers; and specialists in computer risk modeling and planning, training and local community interface.

D. Call for papers/topic and theme areas

Papers could cover any one or a combination of the listed topic areas and sub-areas as well as areas not listed. For ‘non-listed’ areas, the author should show how the subject does fit with the theme of the CBMTS V. Please consider the theoretical as well as the practical and the scientific and operational in problem definition, preparation and response. The importance of local, national, regional, and international preparation and response will be of the highest interest to all professionals attending the CBMTS V.
The following listed major topic, sub-topic areas will be further updated and changed per participants’ requests and at planned meetings of the CBMTS Planning Group at the Spiez Laboratory in Spiez, Switzerland.
(Important Note: CBMTS V will be held under the CBMTS rules that state all participants will present a Science Review Committee approved paper either from the podium or from a poster. Additionally, the CBMTS V Symposium has a physical limit of approximately 130 participants maximum and this will also limit the number of Papers that may be accepted.)

E. The proposed topic areas (and sub-areas are the guide for the proposed papers):

1. CBR Agents: characterization and mode of action
2. Analysis: identification, quantitation of substances; threat assessment; rapid differentiation between biological, toxin and chemical incidents.
3. Prevention: includes threat consideration, terrorists acts, acts of war, industrial accidents and incidents, considerations in CW destruction.
4. Protection and decontamination: includes operational, physical, and medical including prophylaxis.
5. Mass Casualty Management: CBR victims in the event of major accidents or incidents and fromwar/combat actions or terrorist attacks to include differentiation, identification, prevention, pre-planning, organization, and interface with military/civil medical authorities.
6. Treatment: CBR casualties from short to long term and follow up.
7. Terrorism: its effect on the civilian and military communities. These topics from across the CBR spectrum include new chemical agents, biological agents, toxins, new treatments, bioterrorism, new detection and decontamination capabilities as apply to CBR casualties, and etc.
8. Training: of First Responders in terrorism, accidents, and incidents when reliance on other government agencies such as military is not feasible.
9. Medical issues include: Pharmaceutical and Medical Equipment Stockpiles; Medical Countermeasures; Commercial and Regulatory issues; Infectious diseases; Public Health Preparedness; Vaccine development and distribution and legal issues

Note: For questions on applicability of proposed papers, the Science Review Committee will help determine either the proper area or they will form a new area.

The below outline provides guidance on the individual session areas as formulated from the proposed topic areas. The CBMTS members may recommend additional areas and/or changes, which will be considered by the CBMTS V Science Advisor and Science Review Committee.

Major Session Areas

1. Medical treatment


Nerve and blistering agents, HCN, irritants, industrial toxic compounds (list 3)
Mid- and long term effects
Means (protection, decontamination, antidotes) and preparation/instruction of first responders; concepts and reality
Mass casualty handling: triage, civilians, children, babies, decontamination on site, hospital
Detection on site
Outlook on novel threats
Oximes: which one for what agent


Agents of concern: biotoxins, pathogenic organisms
Hospital capacities and capabilities
Ranking of threat
Diagnosis, diagnostic kits
Vaccines, antisera and other treatments; state of the art on new ones, on clinical trials


Detection of contamination
Medication, standard treatment
Long term effects: medical, psychological

2. Mass casualty management

Plans for community, industry

Actual state of the art
Lesson from exercises: what worked and what did not
Training of first responders
On hand equipment and procedures

3. Terrorism

Deliberate distribution through human vectors
Novel agents
Zoonosis (spreading of animal diseases in humans)

4. Pharmaceuticals and Vaccines

Protective medication
Preventive vaccination

5. Detectors and Decontamination

6. Physical and Individual Protection

Protective Clothing
Protective Equipment


Additional Information

Registration Fee Individual Members before 25 Feb after 25 Feb Government/Academia CHF 890 CHF 1080 Industry CHF 1180 CHF 1390 The Registration Fee includes: * all lunches at the Laboratory Dining Room from Monday 26 April through Friday 30 April 2004 all dinners at the Hotel Royal St. Georges in Interlaken from Monday 26 April through Friday 30 April 2004 Welcome Party on Sunday evening Symposium Dinner Program, Proceedings, Symposium bag, local transportation for scheduled events and other items Excursion and Farewell Party with Dinner * Accompanying Persons Fees: Lunch CHF 16, Dinner CHF 28, Welcome Party CHF 30, Symposium Dinner CHF 90, Excursion and Dinner CHF 50. * The excursion includes the Tr¸mmelbach Waterfalls and its ten glacial water falls inside the mountain. Made accessible by tunnel lift, the Tr¸mmelbach waterfalls are truly unique in Europe. Tr¸mmelbach alone drains the enormous glacial walls of the Eiger (3970 m), M–nch (4099 m) and Jungfrau (4158 m) with up to a spectacular 20,000 litres of water per second. This stems from a catchment area of 24 square kilometers of which approximately half is covered with snow and ice. After this excursion and if possible, we will have a boat ride on Lake Brenz to include the farewell dinner. The CBMTS web address: For the CBMTS V team: 1. ASA. CBMTS and International: Richard Price at tel: 1-410-638-9480 and fax: 1-410-638-9481 and e-mail: and 2. Spiez Laboratory and Switzerland. Irma Lehnherr at tel: 41-33-228-1586 and fax: 41-33-228-1402 and e-mail: 3. CBMTS Science:Prof. Urs Brodbeck through cbmts@asanltr.comand . Note: On all message traffic, please include the ASA and Spiez Laboratory e-mail and/or fax addresses and the word CBMTS in the subject.